Twenty years on, survivors of testicular cancer still have large amounts of
platinum circulating in their blood, from their chemotherapy. A team from the
University of Groningen in the Netherlands examined 61 men who had been treated
with the platinum-containing drug cisplatin. Between 10 and 20 years later the
men had an average of 65 picograms per gram of plasma. Among 20 controls, who
survived testicular cancer without chemotherapy, 18 had no platinum and two had
only traces (The Lancet, vol 355, p 1075). The team says the drug’s
persistence justifies research into long-term side effects.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
The biggest threat to Chernobyl is no longer radiation
2
Neanderthal infants were enormous compared with modern humans
3
Largest ever map of universe captures 47 million galaxies and quasars
4
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
5
How to spot the Lyrid meteor shower tonight
6
Monkeys walk around a virtual world using only their thoughts
7
People are refusing transfusions from donors vaccinated against covid
8
Our dreams become more emotive and symbolic as we approach death
9
A key solution to climate change isn't happening – and that's good
10
Emperor penguins added to endangered list after rapid decline



